SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-04-000384
Filing Date
2004-04-23
Accepted
2004-04-23 14:45:14
Documents
15
Period of Report
2004-06-11
Effectiveness Date
2004-04-23

Document Format Files

Seq Description Document Type Size
1 d14406.htm DEF 14A 431183
3 GRAPHIC baker.jpg GRAPHIC 5669
4 GRAPHIC brown-photo.jpg GRAPHIC 5733
5 GRAPHIC d14406line.jpg GRAPHIC 36184
6 GRAPHIC gilman.jpg GRAPHIC 5642
7 GRAPHIC goldstein.jpg GRAPHIC 5475
8 GRAPHIC proy_vangelos-sig.jpg GRAPHIC 78449
9 GRAPHIC regeneronlogo.jpg GRAPHIC 84075
10 GRAPHIC ryan-photo.jpg GRAPHIC 5518
11 GRAPHIC schleifer.jpg GRAPHIC 5749
12 GRAPHIC shooter.jpg GRAPHIC 5995
13 GRAPHIC sing.jpg GRAPHIC 5722
14 GRAPHIC stuart_kolinski-sig.jpg GRAPHIC 233773
15 GRAPHIC vagelos.jpg GRAPHIC 5783
16 GRAPHIC yancopoulos.jpg GRAPHIC 5771
  Complete submission text file 0001206774-04-000384.txt   923661
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19034 | Film No.: 04750666
SIC: 2834 Pharmaceutical Preparations